As long as underlying business/management is good then worrying about bubble is mostly futile. For fresh buys definitely the valuations are stretched for most good pharma companies. but time to time there are good opportunities to buy them like in recent fall there were some good companies at attractive valuations.
How far it can go? – Honestly no one knows that answer.
| Subscribe To Our Free Newsletter |
